Psychiatry & Neurology Doctors in Sikeston, MO Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Mairaj Ahmad Khan, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 760 Plantation Blvd, Sikeston, MO 63801 Phone: 573-471-0800    Fax: 573-471-0810

Enrique Villavicencio Sumire, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 135 Plaza Dr Ste 102, Sikeston, MO 63801 Phone: 573-471-6010

Dr. Riyadh J Tellow, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 807 N Main St, Sikeston, MO 63801 Phone: 573-472-1321    Fax: 573-472-4053

Dr. Syed Afraz Salahuddin, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1019 N Main St, Sikeston, MO 63801 Phone: 573-472-7702    Fax: 573-472-7719

Dr. Syed Muhammad Shahab Sayeed, M.D Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1008 N Main, Missouri Delta Medical Centre, Sikeston, MO 63801 Phone: 573-472-7490    Fax: 573-472-7521

News Archive

New insights into protein p75's role Alzheimer's disease

New research at the Salk Institute for Biological Studies casts the role of a neuronal growth factor receptor - long suspected to facilitate the toxic effects of beta amyloid in Alzheimer's disease - in a new light, suggesting the molecule actually protects the neuron in the periphery from beta amyloid-induced damage.

Alnylam's patisiran receives positive opinion from CHMP for treating hATTR amyloidosis

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Committee for Medicinal Products for Human Use has adopted a Positive Opinion recommending marketing authorization of patisiran for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

Inadequate pain relief common in knee osteoarthritis

Patients with knee osteoarthritis requiring analgesic therapy are often not receiving adequate pain relief, researchers report.

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.

New collaboration may lead to future clinical trials to test treatment for leukemia

In a new pre-clinical study published this week in the journal Leukemia, the research team of Children's Hospital Los Angeles investigator Hisham Abdel-Azim, MD, MS, worked with colleagues to engineer T-cells to identify and target multiple sites on acute lymphoblastic leukemia cells instead of just one. The early collaboration points the way to future clinical trials to test the therapy.

Read more Medical News

› Verified 3 days ago